Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Methotrexate use and risk of lung disease in...
Journal article

Methotrexate use and risk of lung disease in psoriasis, psoriatic arthritis, and inflammatory bowel disease: systematic literature review and meta-analysis of randomised controlled trials

Abstract

OBJECTIVE: To evaluate the relative risk of pulmonary disease among patients with psoriasis, psoriatic arthritis, and inflammatory bowel disease treated with methotrexate. DATA SOURCES: PubMed, Cochrane central register of controlled trials, and Embase to 9 January 2014.

Authors

Conway R; Low C; Coughlan RJ; O'Donnell MJ; Carey JJ

Journal

The BMJ, Vol. 350, No. mar13 17,

Publisher

BMJ

Publication Date

March 13, 2015

DOI

10.1136/bmj.h1269

ISSN

0959-8138